Biotechnology in China is becoming a really big deal.
The world's largest country is aggressively funding grants, building out life sciences facilities, and luring Western research leaders in order to make biotech 4% of its GDP by 2020. At the foundation of this biotech revolution is China's State Drug Administration (their version of the FDA), which recently overhauled its regulatory process to make it faster and easier for new drugs to get approved. The SDA now accepts clinical trial data from other countries and allows drugs to be licensed from others, and they claim to have increased new product approvals by sixfold over previous years.
MSB Trading - 2019, page-24
-
- There are more pages in this discussion • 4,401 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.040(4.52%) |
Mkt cap ! $1.010B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 93.5¢ | 88.0¢ | $1.423M | 1.573M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 40344 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 12939 | 7 |
View Market Depth
| Last trade - 10.36am 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |